arrow
A

Alejandro Arana

epidemiology and risk management
H指数:19
被引数:1,794

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience
2026-01-300
OAAI
Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases

阿立哌唑一月一次给药治疗的抗胆碱能药物使用频率:一项基于欧洲医疗保健数据库的2年队列研究

2025-08-300
OA
A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update

一项多国队列数据库研究,旨在评估在多发性硬化症治疗中,母体或父体潜在暴露于克拉屈滨片后的妊娠及婴儿结局:CLEAR研究的方法与现状更新

2025-01-270
OA
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
2022-12-302
OAAI
Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

局部使用他克莫司和吡美莫司的使用者患皮肤癌和淋巴瘤的长期风险: Protopic联合欧洲纵向淋巴瘤和皮肤癌评估 (JOELLE) 队列研究扩展的最终结果

2021-12-0120
OAAI
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Mirabe使用者与抗毒蕈碱治疗使用者治疗膀胱过度活动症的心血管风险比较: 一项非干预性跨国队列研究的结果

2021-07-087
OAAI